Truist Financial Corp Sells 43,204 Shares of Oak Street Health, Inc. (NYSE:OSH)

Truist Financial Corp lessened its stake in Oak Street Health, Inc. (NYSE:OSH – Get Rating) by 37.1% in the 1st quarter, HoldingsChannel.com reports. The firm owned 73,320 shares of the company’s stock after selling 43,204 shares during the period. Truist Financial Corp’s holdings in Oak Street Health were worth $1,971,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the stock. Capital International Investors raised its position in Oak Street Health by 9.3% in the 4th quarter. Capital International Investors now owns 15,122,281 shares of the company’s stock worth $501,362,000 after purchasing an additional 1,289,911 shares during the last quarter. Capital Research Global Investors raised its position in Oak Street Health by 123.9% in the 4th quarter. Capital Research Global Investors now owns 7,360,139 shares of the company’s stock worth $243,915,000 after purchasing an additional 4,072,919 shares during the last quarter. Capital World Investors raised its position in Oak Street Health by 44.5% in the 4th quarter. Capital World Investors now owns 5,966,260 shares of the company’s stock worth $197,722,000 after purchasing an additional 1,836,533 shares during the last quarter. Maverick Capital Ltd. raised its position in Oak Street Health by 1,464.9% in the 4th quarter. Maverick Capital Ltd. now owns 4,225,127 shares of the company’s stock worth $140,021,000 after purchasing an additional 3,955,127 shares during the last quarter. Finally, Route One Investment Company L.P. raised its position in Oak Street Health by 33.6% in the 4th quarter. Route One Investment Company L.P. now owns 2,968,537 shares of the company’s stock worth $98,377,000 after purchasing an additional 746,287 shares during the last quarter. Institutional investors own 91.42% of the company’s stock.

Insider Transactions at Oak Street Health

In other Oak Street Health news, insider Geoffrey M. Price sold 120,000 shares of the stock in a transaction dated Tuesday, May 31st. The shares were sold at an average price of $18.91, for a total value of $2,269,200.00. Following the transaction, the insider now directly owns 1,893,270 shares of the company’s stock, valued at approximately $35,801,735.70. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Oak Street Health news, insider Geoffrey M. Price sold 62,800 shares of the firm’s stock in a transaction that occurred on Tuesday, July 12th. The shares were sold at an average price of $22.41, for a total value of $1,407,348.00. Following the sale, the insider now owns 1,733,270 shares in the company, valued at $38,842,580.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Geoffrey M. Price sold 120,000 shares of the firm’s stock in a transaction on Tuesday, May 31st. The shares were sold at an average price of $18.91, for a total transaction of $2,269,200.00. Following the transaction, the insider now directly owns 1,893,270 shares of the company’s stock, valued at approximately $35,801,735.70. The disclosure for this sale can be found here. Insiders sold a total of 339,368 shares of company stock worth $6,603,450 in the last three months. Insiders own 11.40% of the company’s stock.

Wall Street Analysts Forecast Growth

OSH has been the subject of several recent research reports. Bank of America cut shares of Oak Street Health from a “buy” rating to an “underperform” rating and dropped their target price for the company from $26.00 to $18.00 in a research report on Wednesday, June 15th. UBS Group initiated coverage on shares of Oak Street Health in a research report on Wednesday, April 20th. They set a “neutral” rating and a $26.00 target price for the company. Guggenheim initiated coverage on shares of Oak Street Health in a research report on Tuesday, March 29th. They set a “neutral” rating for the company. Barclays upped their target price on shares of Oak Street Health from $27.00 to $31.00 and gave the company an “overweight” rating in a research report on Tuesday, April 19th. Finally, Stifel Nicolaus initiated coverage on shares of Oak Street Health in a research report on Thursday, May 26th. They set a “buy” rating and a $25.00 target price for the company. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $34.19.

Oak Street Health Price Performance

Shares of NYSE OSH opened at $24.75 on Wednesday. The firm has a market cap of $5.97 billion, a PE ratio of -12.50 and a beta of 2.21. The company has a current ratio of 1.79, a quick ratio of 1.79 and a debt-to-equity ratio of 16.10. Oak Street Health, Inc. has a 1-year low of $13.29 and a 1-year high of $65.22. The company has a fifty day moving average price of $18.60 and a 200 day moving average price of $20.44.

Oak Street Health (NYSE:OSH – Get Rating) last announced its earnings results on Tuesday, May 3rd. The company reported ($0.43) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.04). Oak Street Health had a negative return on equity of 413.94% and a negative net margin of 26.82%. The company had revenue of $513.80 million during the quarter, compared to analyst estimates of $506.82 million. During the same period in the previous year, the company posted ($0.29) earnings per share. Oak Street Health’s revenue for the quarter was up 73.2% on a year-over-year basis. Research analysts predict that Oak Street Health, Inc. will post -2.2 earnings per share for the current fiscal year.

Oak Street Health Profile

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.